{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:06:16Z","timestamp":1794657976382,"version":"4.9.1"},"reference-count":90,"publisher":"Annual Reviews","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annu. Rev. Med."],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:p> \u25aa Abstract\u2002 Neurocysticercosis is now recognized as a common cause of neurologic disease in developing countries and the United States. The pathogenesis and clinical manifestations vary with the site of infection and accompanying host response. Inactive infection should be treated symptomatically. Active parenchymal infection results from an inflammatory reaction to the degenerating cysticercus and will also respond to symptomatic treatment. Controlled trials have not demonstrated a clinical benefit for antiparasitic drugs. Ventricular neurocysticercosis often causes obstructive hydrocephalus. Surgical intervention, especially cerebrospinal fluid diversion, is the key to management of hydrocephalus. Shunt failure may be less frequent when patients are treated with prednisone and\/or antiparasitic drugs. Subarachnoid cysticercosis is associated with arachnoiditis. The arachnoiditis may result in meningitis, vasculitis with stroke, or hydrocephalus. Patients should be treated with corticosteroids, antiparasitic drugs, and shunting if hydrocephalus is present. <\/jats:p>","DOI":"10.1146\/annurev.med.51.1.187","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T11:45:04Z","timestamp":1027770304000},"page":"187-206","source":"Crossref","is-referenced-by-count":275,"title":["Neurocysticercosis: Updates on Epidemiology, Pathogenesis, Diagnosis, and Management"],"prefix":"10.1146","volume":"51","author":[{"suffix":"Jr.","given":"A. Clinton","family":"White","sequence":"first","affiliation":[{"name":"Infectious Disease Section, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, Texas, 77030, ;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22","reference":[{"key":"b1","doi-asserted-by":"crossref","unstructured":"Schantz PM, Wilkins PP, Tsang VCW. 1998. Immigrants, imaging, and immunoblots: the emergence of neurocysticercosis as a major public health problem. InEmerging Infections 2,ed. WM Scheld, WA Craig, JM Hughes, pp. 213\u2013 42. Washington, DC: Am. Soc. Microbiol.","DOI":"10.1128\/9781555816957.ch12"},{"key":"b2","doi-asserted-by":"crossref","unstructured":"White AC Jr. 1997. State-of-the-art: neurocysticercosis: a common cause of neurologic disease worldwide.Clin. Infect. Dis.24:101\u201313","DOI":"10.1093\/clinids\/24.2.101"},{"key":"b3","unstructured":"Del Brutto OH, Sotelo J, Roman GC. 1998.Neurocysticercosis: A Clinical Handbook.Exton, PA: Swets & Zeitlinger"},{"key":"b4","unstructured":"McCormick GF. 1985. Cysticercosis: review of 230 patients.Bull. Clin. Neurosci.50:76\u2013101"},{"key":"b5","doi-asserted-by":"crossref","unstructured":"Shandera WX, White AC Jr, Chen J, et al. 1994. Cysticercosis in Houston, Texas: a report of 112 cases.Medicine73:37\u201352","DOI":"10.1097\/00005792-199401000-00004"},{"key":"b6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209033271004"},{"key":"b7","doi-asserted-by":"crossref","unstructured":"Sorvillo FJ, Waterman SH, Richards FO, Schantz PM. 1992. Cysticercosis surveillance: locally acquired and travelrelated infection and detection of intestinal tapeworm carriers in Los Angeles.Am. J. Trop. Med. Hyg.47:365\u201371","DOI":"10.4269\/ajtmh.1992.47.365"},{"key":"b8","doi-asserted-by":"crossref","unstructured":"Tsang VCW, Brand JA, Boyer AE. 1989. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium).J. Infect. Dis.159:50\u201359","DOI":"10.1093\/infdis\/159.1.50"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.150.2.325"},{"key":"b10","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6974(94)90118-X"},{"key":"b11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1994.tb02916.x"},{"key":"b12","doi-asserted-by":"crossref","unstructured":"Schantz PM, Sarti E, Plancarte A, et al. 1994. Community-based epidemiological investigation of cysticercosis due toTaenia solium:comparison of serological screening tests and clinical findings in two populations in Mexico.Clin. Infect. Dis.18:879\u201385","DOI":"10.1093\/clinids\/18.6.879"},{"key":"b13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1995.hed3502093.x"},{"key":"b14","unstructured":"Preux PM, Melaku Z, Druet-Cabanac M, et al. 1996. Cysticercosis and neurocysticercosis in Africa: current status.Neurol. Infect. Epidemiol.1:63\u201368"},{"key":"b15","first-page":"327","volume":"80","year":"1991","journal-title":"S. Afr. Med. J."},{"key":"b16","unstructured":"Dumas M, Grunitzky K, Belo M, et al. 1990. Cysticercosis and neurocysticercosis: epidemiological survey in North Togo.Bull. Soc. Pathol. Exot.83:263\u201374"},{"key":"b17","doi-asserted-by":"crossref","unstructured":"Andriantsimahavandy A, Lesbordes JL, Rasoaharimalala B, et al. 1997. Neurocysticercosis: a major aetiological factor of late-onset epilepsy in Madagascar.Trop. Med. Int. Health2:741\u201346","DOI":"10.1046\/j.1365-3156.1997.d01-379.x"},{"key":"b18","doi-asserted-by":"crossref","unstructured":"Chandy MJ, Rajshekhar V, Ghosh S, et al. 1991. Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations.J. Neurol. Neurosurg. Psychiatr.54:702\u20135","DOI":"10.1136\/jnnp.54.8.702"},{"key":"b19","first-page":"76","volume":"96","year":"1997","journal-title":"Acta Neurol. Scand."},{"key":"b20","doi-asserted-by":"crossref","unstructured":"Murthy JMK, Yangala R. 1998. Etiological spectrum of symptomatic localization related epilepsies: a study from South India.J. Neurol. Sci.158:65\u201370","DOI":"10.1016\/S0022-510X(98)00093-8"},{"key":"b21","first-page":"4","volume":"25","year":"1994","journal-title":"SE Asian J. Trop. Med. Publ. Health"},{"key":"b22","doi-asserted-by":"crossref","unstructured":"Kong Y, Cho SY, Cho MS, et al. 1993. Seroepidemiological observation ofTaenia soliumcysticercosis in epileptic patients in Korea.J. Korean Med. Sci.82:145\u201352","DOI":"10.3346\/jkms.1993.8.2.145"},{"key":"b23","unstructured":"de la Garza Y, Graviss E, Shandera W, et al. 1998.Epidemiology of neurocysticercosis in Houston, Texas.Presented at Int. Conf. Emerging Infect. Dis., Atlanta, GA"},{"key":"b24","doi-asserted-by":"crossref","unstructured":"White AC Jr, Robinson P, Kuhn R. 1997.Taenia soliumcysticercosis: hostparasite interactions and the immune response. InImmunopathogenetic Aspects of Disease Induced by Helminth Parasites,ed. DO Freedman. In ser.ChemicalImmunology66:209\u2013230. Basel: Karger","DOI":"10.1159\/000058663"},{"key":"b25","doi-asserted-by":"crossref","unstructured":"Arechavaleta F, Molinari JL, Tato P. 1998. ATaeniasoliummetacestode factor nonspecifically inhibits cytokine production.Parasitol. Res.84:117\u201322","DOI":"10.1007\/s004360050367"},{"key":"b26","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1128\/iai.65.7.2925-2931.1997","volume":"65","year":"1997","journal-title":"Infect. Immun."},{"key":"b27","unstructured":"Dixon HBF, Lipscomb FM. 1961. Cysticercosis: an analysis and follow-up of 450 cases. InMed. Res. Counc. Spec. Rep. Ser. 299,pp. 1\u201358. London: Her Majesty\u2019s Stationary Office"},{"key":"b28","doi-asserted-by":"crossref","unstructured":"Ridaura Sanz C. 1987. Host response in childhood neurocysticercosis: some pathological aspects.Child. Nerv. Syst.3:206\u20137","DOI":"10.1007\/BF00274046"},{"key":"b29","unstructured":"Escobar A. 1983. The pathology of neurocysticercosis. InCysticercosis of the Central Nervous System,ed. E Palacios, J Rodriguez-Carbajal, J Taveras, pp. 27\u2013 54. Springfield, IL: Thomas"},{"key":"b30","doi-asserted-by":"crossref","unstructured":"Restrepo BI, Llaguno P, Sandoval MA, et al. 1998. Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2.J. Neuroimmunol.89:64\u201372","DOI":"10.1016\/S0165-5728(98)00112-X"},{"key":"b31","doi-asserted-by":"crossref","unstructured":"Esta\u00f1ol B, Kleriga E, Loyo M, et al. 1983. Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy.Neurosurgery13:119\u201323","DOI":"10.1097\/00006123-198308000-00002"},{"key":"b32","doi-asserted-by":"crossref","unstructured":"Bandres J, White AC Jr, Samo T, et al. 1992. Extraparenchymal neurocysticercosis: report of five cases and review of the literature on management.Clin. Infect. Dis.15:799\u2013822","DOI":"10.1093\/clind\/15.5.799"},{"key":"b33","doi-asserted-by":"crossref","unstructured":"Zee C-S, Segall HD, Destain S, et al. 1993. MRI of intraventricular cysticercosis: surgical implication.J. Comput. Assist. Tomogr.17:932\u201339","DOI":"10.1097\/00004728-199311000-00015"},{"key":"b34","doi-asserted-by":"crossref","unstructured":"Cant\u00fa C, Barinagarrementeria MD. 1996. Cerebrovascular complications of neurocysticercosis: clinical and neuroimaging spectrum.Arch. Neurol.53:233\u201339","DOI":"10.1001\/archneur.1996.00550030039021"},{"key":"b35","doi-asserted-by":"crossref","unstructured":"Sotelo J, Guerrero V, Rubio F. 1985. Neurocysticercosis: a new classification based on active and inactive forms.Arch. Intern. Med.145:442\u201345","DOI":"10.1001\/archinte.145.3.442"},{"key":"b36","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100048757"},{"key":"b37","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.157.17.1991"},{"key":"b38","doi-asserted-by":"crossref","unstructured":"Esta\u00f1ol B, Corona T, Abad P. 1986. A prognostic classification of cerebral cysticercosis: therapeutic implications.J. Neurol. Neurosurg. Psychiatr.49:1131\u2013 34","DOI":"10.1136\/jnnp.49.10.1131"},{"key":"b39","doi-asserted-by":"crossref","unstructured":"Kramer LD, Locke GE, Byrd SE. 1989. Cerebral cysticercosis: documentation of natural history by CT.Radiology171:459\u201362","DOI":"10.1148\/radiology.171.2.2704811"},{"key":"b40","doi-asserted-by":"crossref","unstructured":"Dumas JL, Visy JM, Belin C, et al. 1997. Parenchymal neurocysticercosis: followup and staging by MRI.Neuroradiology39:12\u201318","DOI":"10.1007\/s002340050358"},{"key":"b41","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9260(88)80232-0"},{"key":"b42","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1992.00530290123021"},{"key":"b43","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199102000-00009"},{"key":"b44","doi-asserted-by":"publisher","DOI":"10.1097\/00004728-198811000-00004"},{"key":"b45","doi-asserted-by":"crossref","unstructured":"Barinagarrementeria F, Cantu C. 1998. Frequency of cerebral arteritis in subarachnoid cysticercosis: an angiographic study.Stroke29:123\u201325","DOI":"10.1161\/01.STR.29.1.123"},{"key":"b46","doi-asserted-by":"crossref","unstructured":"Leite CC, Jinkins JR, Escobar BE, et al. 1997. MR imaging of intramedullary and intradural-extramedullary spinal cysticercosis.Am. J. Roentgenol.169:1713\u2013 17","DOI":"10.2214\/ajr.169.6.9393195"},{"key":"b47","unstructured":"Cardenas F, Quiroz H, Plancarte A, et al. 1992.Taenia soliumocular cysticercosis: findings in 30 cases.Ann. Ophthalmol.24:25\u201328"},{"key":"b48","doi-asserted-by":"crossref","unstructured":"Carpio A, Escobar A, Hauser WA. 1998. Cysticercosis and epilepsy: a critical review.Epilepsia39:1025\u201340","DOI":"10.1111\/j.1528-1157.1998.tb01287.x"},{"key":"b49","doi-asserted-by":"crossref","unstructured":"Del Brutto OH, Santiba\u00f1ez R, Noboa CA, et al. 1992. Epilepsy due to neurocysticercosis: analysis of 203 patients.Neurology42:389\u201392","DOI":"10.1212\/WNL.42.2.389"},{"key":"b50","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.9.1706"},{"key":"b51","first-page":"79","volume":"19","year":"1998","journal-title":"Am. J. Neuroradiol."},{"key":"b52","doi-asserted-by":"crossref","unstructured":"Levav M, Mirsky AF, Cruz ME, Cruz I. 1995. Neurocysticercosis and performance on neuropsychologic tests: a family study in Ecuador.Am. J. Trop. Med. Hyg.53:552\u201357","DOI":"10.4269\/ajtmh.1995.53.552"},{"key":"b53","doi-asserted-by":"crossref","unstructured":"Ruiz-Garcia M, Gonzalez-Astiazaran A, Rueda-Franco R. 1997. Neurocysticercosis in children: clinical experience in 122 patients.Child. Nerv. Syst.13:608\u2013 12","DOI":"10.1007\/s003810050152"},{"key":"b54","doi-asserted-by":"crossref","unstructured":"Forlenza OV, Filho AHGV, Nobrega JPS, et al. 1997. Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil.J. Neurol. Neurosurg. Psychiatr.62:612\u201316","DOI":"10.1136\/jnnp.62.6.612"},{"key":"b55","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(96)00130-X"},{"key":"b56","doi-asserted-by":"crossref","unstructured":"Ramos-Kuri M, Montoya RS, Padilla A, et al. 1992. Immunodiagnosis of neurocysticercosis: disappointing performance of serology (ELISA) in an unbiased sample of neurologic patients.Arch. Neurol.49:633\u201336","DOI":"10.1001\/archneur.1992.00530300069012"},{"key":"b57","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/164.5.1007"},{"key":"b58","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.2.486"},{"key":"b59","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(98)91069-0"},{"key":"b60","unstructured":"Mitchell WG, Crawford TO. 1988. Intraparenchymal cerebral cysticercosis in children: diagnosis and treatment.Pediatrics82:76\u201382"},{"key":"b61","doi-asserted-by":"crossref","unstructured":"Carpio A, Santill\u00e1n F, Le\u00f3n P, et al. 1995. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?Arch. Intern. Med.155:1982\u201388","DOI":"10.1001\/archinte.155.18.1982"},{"key":"b62","doi-asserted-by":"crossref","unstructured":"Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. 1998. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebocontrolled, double blind trial.Pediatr. Infect. Dis. J.7:696\u2013700","DOI":"10.1097\/00006454-199808000-00007"},{"key":"b63","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.9.1561"},{"key":"b64","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.492"},{"key":"b65","doi-asserted-by":"crossref","unstructured":"Dachman WD, Adubofour KO, Bikin DS, et al. 1994. Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants.J. Infect. Dis.169:689\u2013 91","DOI":"10.1093\/infdis\/169.3.689"},{"key":"b66","doi-asserted-by":"crossref","unstructured":"Bittencourt PR, Gracia CM, Gorz AM, et al. 1990. High-dose praziquantel for neurocysticercosis: efficacy and tolerability.Eur. Neurol.30:229\u201334","DOI":"10.1159\/000117352"},{"key":"b67","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.5.1079"},{"key":"b68","doi-asserted-by":"crossref","unstructured":"De Ghetaldi LD, Norman RM, Couville AW. 1983. Cerebral cysticercosis treated biphasically with dexamethasone and praziquantel.Ann. Intern. Med.99:179\u2013 81","DOI":"10.7326\/0003-4819-99-2-179"},{"key":"b69","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.147.4.738"},{"key":"b70","doi-asserted-by":"crossref","unstructured":"Garcia HH, Gilman RH, Horton J, et al. 1997. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.Neurology48:1421\u201327","DOI":"10.1212\/WNL.48.5.1421"},{"key":"b71","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314663"},{"key":"b72","doi-asserted-by":"crossref","unstructured":"Padma MV, Behari M, Misra NK, Ahuja GK. 1994. Albendazole in single CT ring lesions in epilepsy.Neurology44:1344\u2013 46","DOI":"10.1212\/WNL.44.7.1344"},{"key":"b73","first-page":"255","volume":"8","year":"1995","journal-title":"Natl. Med. J. India"},{"key":"b74","doi-asserted-by":"crossref","unstructured":"Salinas R, Prasad K. 1999. Drugs for treating neurocysticercosis (tapeworm infection of the brain) (Cochrane Review).The Cochrane Library, Issue 1.Oxford: Update Software. http:\/\/www.updateusa.com\/cochrane.htm","DOI":"10.1002\/14651858.CD000215.pub2"},{"key":"b75","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1984.60.2.0400"},{"key":"b76","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-3019(97)00179-1"},{"key":"b77","doi-asserted-by":"crossref","unstructured":"Neal JH. 1995. An endoscopic approach to cysticercosis cysts of the posterior third ventricle.Neurosurgery36:1040\u2013 43","DOI":"10.1097\/00006123-199505000-00026"},{"key":"b78","doi-asserted-by":"crossref","unstructured":"Suastegui Roman R, Soto-Hernandez J, Sotelo J. 1996. Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study.J. Neurosurg.84:629\u201333","DOI":"10.3171\/jns.1996.84.4.0629"},{"key":"b79","doi-asserted-by":"crossref","unstructured":"Sotelo J, Rubalcava MA, Gomez-Llata S. 1995. A new shunt for hydrocephalus that relies on CSF production rather than on ventricular pressure: initial clinical experiences.Surg. Neurol.43:324\u201331","DOI":"10.1016\/0090-3019(95)80057-N"},{"key":"b80","doi-asserted-by":"crossref","unstructured":"Sotelo J. 1996. Update: the new ventriculoperitoneal shunt at the Institute of Neurology of Mexico.Surg. Neurol.46:19\u201320","DOI":"10.1016\/0090-3019(96)00098-5"},{"key":"b81","doi-asserted-by":"crossref","unstructured":"Martinez HR, Rangel-Guerra R, Arrendondo-Estrada JH, et al. 1995. Medical and surgical treatment of neurocysticercosis: a magnetic resonance study of 161 cases.J. Neurol. Sci.130:25\u201334","DOI":"10.1016\/0022-510X(94)00278-V"},{"key":"b82","doi-asserted-by":"crossref","unstructured":"Cuetter A, Garcia-Bobadilla J, Guerra L, et al. 1997. Neurocysticercosis: focus on intraventricular disease.Clin. Infect. Dis.24:157\u201364","DOI":"10.1093\/clinids\/24.2.157"},{"key":"b83","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1997.87.1.0029"},{"key":"b84","doi-asserted-by":"crossref","unstructured":"Sotelo J, Torres B, Rubio-Donnadieu F, et al. 1985. Praziquantel in the treatment of neurocysticercosis: long-term followup.Neurology35:752\u201355","DOI":"10.1212\/WNL.35.5.752"},{"key":"b85","first-page":"154","volume":"77","year":"1990","journal-title":"S. Afr. Med. J."},{"key":"b86","doi-asserted-by":"crossref","unstructured":"Sotelo J, Marin C. 1987. Hydrocephalus secondary to cysticercotic arachnoiditis: a long-term follow-up review of 92 cases.J. Neurosurg.66:686\u201389","DOI":"10.3171\/jns.1987.66.5.0686"},{"key":"b87","doi-asserted-by":"crossref","unstructured":"Del Brutto OH. 1997. Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients.J. Neurol. Neurosurg. Psychiatr.62:659\u201361","DOI":"10.1136\/jnnp.62.6.659"},{"key":"b88","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199701000-00018"},{"key":"b89","doi-asserted-by":"publisher","DOI":"10.1097\/00007632-199610010-00023"},{"key":"b90","doi-asserted-by":"crossref","unstructured":"Garg RK, Nag D. 1998. Intramedullary spinal cysticercosis: response to albendazole: case reports and review of the literature.Spinal Cord36:67\u201370","DOI":"10.1038\/sj.sc.3100526"}],"container-title":["Annual Review of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.annualreviews.org\/doi\/pdf\/10.1146\/annurev.med.51.1.187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:01:35Z","timestamp":1634169695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.annualreviews.org\/doi\/10.1146\/annurev.med.51.1.187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1146\/annurev.med.51.1.187"],"URL":"https:\/\/doi.org\/10.1146\/annurev.med.51.1.187","relation":{},"ISSN":["0066-4219","1545-326X"],"issn-type":[{"value":"0066-4219","type":"print"},{"value":"1545-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}